{"content":"<li class=\"n-box-item date-title\" data-end=\"1389675599\" data-start=\"1389589200\" data-txt=\"Saturday, December 21, 2019\">Monday, January 13, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"1505501\" data-ts=\"1389656863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLR\" target=\"_blank\">FLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505501-fluor-jv-awarded-epc-contract-for-kitimat-lng-project-shares-plus-1_7-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fluor JV awarded EPC contract for Kitimat LNG project, shares +1.7% AH</a></h4><ul>     <li>Fluor (NYSE:<a href=\"https://seekingalpha.com/symbol/FLR\" title=\"Fluor Corporation\">FLR</a>) <font color=\"green\">+1.7%</font> AH after a joint venture with JGC wins a contract for engineering, procurement and construction of the Kitimat liquefied natural gas facility in  British Columbia.</li>     <li>The project scope includes completion of the existing FEED package by finalizing value-improving concepts for the proposed LNG facility, as well as detailed engineering and procurement  services for the project's initial phases.</li>\n<li>Chevron (NYSE:<a href=\"https://seekingalpha.com/symbol/CVX\" title=\"Chevron Corporation\">CVX</a>) and Apache (NYSE:<a href=\"https://seekingalpha.com/symbol/APA\" title=\"Apache Corporation\">APA</a>) each hold a 50% interest in the proposed project.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1505501\" data-linked=\"Fluor JV awarded EPC contract for Kitimat LNG project, shares +1.7% AH\" data-tweet=\"$FLR $FLR $CVX - Fluor JV awarded EPC contract for Kitimat LNG project, shares +1.7% AH https://seekingalpha.com/news/1505501-fluor-jv-awarded-epc-contract-for-kitimat-lng-project-shares-plus-1_7-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1505501-fluor-jv-awarded-epc-contract-for-kitimat-lng-project-shares-plus-1_7-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505481\" data-ts=\"1389656220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUTO\" target=\"_blank\">AUTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505481-autobytel-acquires-autonation-subsidiary-plus-12_3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autobytel acquires AutoNation subsidiary, +12.3% AH</a></h4><ul>     <li>Autobytel (ABTL) <font color=\"green\">+12.3%</font> AH after agreeing to acquire AutoNation (NYSE:<a href=\"https://seekingalpha.com/symbol/AN\" title=\"AutoNation Inc\">AN</a>) subsidiary AutoUSA for $10M in cash and a $1M 6% convertible note payable in one lump sum in five years and convertible to ABTL common stock at a conversion price reflecting a 20% premium over the price of ABTL shares on the date of closing.</li>     <li>ABTL says the acquisition expands its reach and influence in the industry by increasing its national new and used car dealer network to more than 5,200 from ~3,800 while boosting its business with auto manufacturers.</li>     <li>ABTL expects the deal will be accretive to its 2014 results.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505481\" data-linked=\"Autobytel acquires AutoNation subsidiary, +12.3% AH\" data-tweet=\"$AUTO $AUTO $AN - Autobytel acquires AutoNation subsidiary, +12.3% AH https://seekingalpha.com/news/1505481-autobytel-acquires-autonation-subsidiary-plus-12_3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1505481-autobytel-acquires-autonation-subsidiary-plus-12_3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505471\" data-ts=\"1389655643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APU\" target=\"_blank\">APU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505471-amerigas-partners-selling-shareholder-to-offer-8m-units-minus-4_7-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmeriGas Partners selling shareholder to offer 8M units, -4.7% AH</a></h4><ul><li>AmeriGas Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/APU\" title=\"AmeriGas Partners LP\">APU</a>) <font color=\"red\">-4.7%</font> AH on news that selling shareholder Heritage ETC, an affiliate of Energy Transfer  Partners (ETP),  will offer 8M APU common units it currently   holds.</li></ul><div class=\"tiny-share-widget\" data-id=\"1505471\" data-linked=\"AmeriGas Partners selling shareholder to offer 8M units, -4.7% AH\" data-tweet=\"$APU $APU $ET - AmeriGas Partners selling shareholder to offer 8M units, -4.7% AH https://seekingalpha.com/news/1505471-amerigas-partners-selling-shareholder-to-offer-8m-units-minus-4_7-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1505471-amerigas-partners-selling-shareholder-to-offer-8m-units-minus-4_7-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505411\" data-ts=\"1389652826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505411-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/ELON' title='Echelon Corporation'>ELON</a> <font color='green'>+10.1%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='green'>+9.4%</font>. <a href='https://seekingalpha.com/symbol/UBSI' title='United Bankshares, Inc.'>UBSI</a> <font color='green'>+4.4%</font>. <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/FEI' title='First Trust MLP&Energy Income Fund'>FEI</a> <font color='green'>+2.7%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color='red'>-4.8%</font>. <a href='https://seekingalpha.com/symbol/APU' title='AmeriGas Partners LP'>APU</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-4.5%</font>. <a href='https://seekingalpha.com/symbol/KBR' title='KBR, Inc.'>KBR</a> <font color='red'>-4.0%</font>. <a href='https://seekingalpha.com/symbol/HT' title='Hersha Hospitality Trust'>HT</a> <font color='red'>-3.9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1505411\" data-linked=\"After hours Gainers / Losers\" data-tweet=\"$ELON $NLS $UBSI - After hours Gainers / Losers https://seekingalpha.com/news/1505411-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1505411-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505341\" data-ts=\"1389650267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505341-noodles-comp-sales-slightly-worse-than-originally-reported\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noodles comp sales slightly worse than originally reported</a></h4><ul>\n<li>Noodles &amp; Company (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NDLS\" title=\"Noodles &amp; Company\">NDLS</a>) corrects an earlier statement of preliminary Q4 results, expecting system-wide comparable store sales growth of 3.9%, not 4.3%. Comparable sales for company-owned restaurants are expected to be 4.3% higher, while those for franchised restaurants are expected to gain 1.5%.</li>\n<li>Other figures are the same: Total revenue is expected to be up 17.4% to $91.5M, and 12 new restaurants opened in Q4 - 8 company-owned, and 4 franchised.</li>\n<li>The numbers are less than hoped (the stock <font color=\"red\">fell 5.3%</font> in the regular session), and CEO Kevin Ruddy mentions \"significant weather headwinds.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505341\" data-linked=\"Noodles comp sales slightly worse than originally reported\" data-tweet=\"$NDLS - Noodles comp sales slightly worse than originally reported https://seekingalpha.com/news/1505341-noodles-comp-sales-slightly-worse-than-originally-reported?source=tweet\" data-url=\"https://seekingalpha.com/news/1505341-noodles-comp-sales-slightly-worse-than-originally-reported\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505271\" data-ts=\"1389649262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505271-workday-announces-6m-share-offering-shares-minus-3-percent-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday announces 6M-share offering, shares -3% AH</a></h4><ul>\n<li>Just seven months after selling $530M worth of convertible debt, Workday (NYSE:<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a>) is selling 6M shares (current value of $510M) in a follow-on offering. Underwriters will have a 900K-share overallotment option. (PR)</li>\n<li>The cloud HR/ERP software vendor says it will use the proceeds for \"working capital and other general corporate purposes, including potential acquisitions of businesses, technologies, or other assets.\" Workday had $1.3B in cash/investments as of Oct. 31, and (thanks to its convertible debt sales) $478M in debt.</li>\n<li>News of the offering comes on a day when Workday made new highs in morning trading, before later retreating.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505271\" data-linked=\"Workday announces 6M-share offering, shares -3% AH\" data-tweet=\"$WDAY - Workday announces 6M-share offering, shares -3% AH https://seekingalpha.com/news/1505271-workday-announces-6m-share-offering-shares-minus-3-percent-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/1505271-workday-announces-6m-share-offering-shares-minus-3-percent-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505231\" data-ts=\"1389648289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RASF\" target=\"_blank\">RASF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505231-rait-minus-3-percent-after-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RAIT -3% after secondary offering</a></h4><ul>\n<li>The offering size is 10M shares with an underwriter greenshoe option for another 1.5M shares. If the option is taken up, the offering will add about 16% to the float.</li>\n<li>RAS <font color=\"red\">-3.2%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505231\" data-linked=\"RAIT -3% after secondary offering\" data-tweet=\"$RASF - RAIT -3% after secondary offering https://seekingalpha.com/news/1505231-rait-minus-3-percent-after-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1505231-rait-minus-3-percent-after-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505201\" data-ts=\"1389648039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATXDY\" target=\"_blank\">ATXDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505201-austex-oil-rallies-on-bullish-article-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AusTex Oil rallies on bullish article mention</a></h4><ul>\n<li>Underfollowed AusTex Oil (<a href=\"https://seekingalpha.com/symbol/ATXDY\" title=\"AusTex Oil Limited ADR\">OTCPK:ATXDY</a>) closes the day with an <font color=\"green\">18%</font> gain.</li>\n<li>The shares are up some <font color=\"green\">28.5%</font> since SA Pro contributor Josh Young penned a <a href=\"https://seekingalpha.com/article/1938351-the-next-great-investment-idea-austex-oil-is-trading-at-1-3-of-proved-reserve-value-growing-300-percent-per-year\" target=\"_blank\">bullish piece</a> on the company last week.</li>\n<li>According to Young, the company's shares \"trade at a large discount to its proved reserve value [and] to comparable companies on a  production valuation basis.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505201\" data-linked=\"AusTex Oil rallies on bullish article mention\" data-tweet=\"$ATXDY - AusTex Oil rallies on bullish article mention https://seekingalpha.com/news/1505201-austex-oil-rallies-on-bullish-article-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/1505201-austex-oil-rallies-on-bullish-article-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505181\" data-ts=\"1389647780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBW\" target=\"_blank\">BBW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505181-build-a-bear-slides-after-disappointing-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Build-A-Bear slides after disappointing guidance</a></h4><ul>\n<li>Comparable store sales are expected to be down 2.2% in Q4 - off 2.8% in North America and 0.1% in Europe. Total revenues of $107M compares to $118.2M a year ago.</li>\n<li>Adjusted pre-tax income after charges is expected at $4M-$7M vs. $3.1M a year ago.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/BBW\" title=\"Build-A-Bear Workshop, Inc.\">BBW</a><font color=\"red\"> -3.1%</font> AH</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505181\" data-linked=\"Build-A-Bear slides after disappointing guidance\" data-tweet=\"$BBW - Build-A-Bear slides after disappointing guidance https://seekingalpha.com/news/1505181-build-a-bear-slides-after-disappointing-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1505181-build-a-bear-slides-after-disappointing-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505151\" data-ts=\"1389647055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505151-mast-therapeutics-posts-enormous-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mast Therapeutics posts enormous gain</a></h4><ul>\n<li>Mast Therapeutics (MSTX) \u2014 which <a href=\"https://seekingalpha.com/news/1492461-mast-therapeutics-rallies-on-heat-failure-data\" target=\"_blank\">got some traction earlier this month</a> after saying MST-188 \"demonstrated a statistically  significant improvement in numerous parameters of heart function,\" in a  nonclinical heart failure model \u2014 closes the day with a <font color=\"green\">57%</font> gain.<br>\n</li>\n<li>Earlier, a <a href=\"http://finance.yahoo.com/news/biotech-bulls-focusing-mast-155815420.html\" target=\"_blank\">trader purchased</a> some 4K July $1 calls \u2014 volume in that strike was triple the existing open interest, according to OptionMonster.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505151\" data-linked=\"Mast Therapeutics posts enormous gain\" data-tweet=\"$SVRA - Mast Therapeutics posts enormous gain https://seekingalpha.com/news/1505151-mast-therapeutics-posts-enormous-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/1505151-mast-therapeutics-posts-enormous-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505121\" data-ts=\"1389646731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LQMT\" target=\"_blank\">LQMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505121-liquidmetal-higher-after-new-apple-patent-applications-uncovered\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liquidmetal higher after new Apple patent applications uncovered</a></h4><ul>\n<li>\n<a href=\"http://www.macrumors.com/2014/01/13/liquidmetal-buttons-sensors-screws/\" target=\"_blank\">MacRumors</a> has discovered a batch of new Apple patent applications, included 17 published last Thursday, related to the use of Liquidmetal (<a href=\"https://seekingalpha.com/symbol/LQMT\" title=\"Liquidmetal Technologies, Inc.\">OTCQB:LQMT</a> <font color=\"green\">+9.2%</font>) alloys. The applications cover button/switch pressure sensors, tamper-resistant screws, and touch sensor substrates, among other potential use cases.</li>\n<li>Liquidmetal shares, which made new 52-week highs last week before retreating, have rallied again on the pink sheets. Shares also <a href=\"https://seekingalpha.com/news/1426041-liquid-metal-higher-after-apple-patent-applications-disclosed\" target=\"_blank\">moved higher  in November</a> in response to Apple patent applications covering Liquidmetal usage.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505121\" data-linked=\"Liquidmetal higher after new Apple patent applications uncovered\" data-tweet=\"$LQMT - Liquidmetal higher after new Apple patent applications uncovered https://seekingalpha.com/news/1505121-liquidmetal-higher-after-new-apple-patent-applications-uncovered?source=tweet\" data-url=\"https://seekingalpha.com/news/1505121-liquidmetal-higher-after-new-apple-patent-applications-uncovered\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505111\" data-ts=\"1389646458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPP\" target=\"_blank\">PPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505111-primero-mining-plus-5_6-percent-after-topping-2013-guidance-sees-more-gains-in-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Primero Mining +5.6% after topping 2013 guidance, sees more gains in &#39;14</a></h4><ul>     <li>Primero Mining (<a href=\"https://seekingalpha.com/symbol/PPP\" title=\"Primero Mining Corp. New Ordinary Shares\">PPP</a> <font color=\"green\">+5.6%</font>) powers higher after saying it exceeded its 2013 production and cost guidance, and it expects a further 15% output increase in 2014.</li>\n<li>Q4 production of 34.3K gold  equiv. oz. resulted in record annual  2013 production of  143.1K gold equiv. oz., 29% higher than 2012.</li>\n<li>Estimated annual 2013 cash  costs fell 6% Y/Yr 2012, with all-in sustaining  costs estimated at $1,072/oz.</li>\n<li>Production at San Dimas is expected to  increase again in 2014 by up to  15% to 155K-165K gold  equiv. oz.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1505111\" data-linked=\"Primero Mining +5.6% after topping 2013 guidance, sees more gains in &#39;14\" data-tweet=\"$PPP - Primero Mining +5.6% after topping 2013 guidance, sees more gains in &#39;14 https://seekingalpha.com/news/1505111-primero-mining-plus-5_6-percent-after-topping-2013-guidance-sees-more-gains-in-14?source=tweet\" data-url=\"https://seekingalpha.com/news/1505111-primero-mining-plus-5_6-percent-after-topping-2013-guidance-sees-more-gains-in-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505091\" data-ts=\"1389645596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTX\" target=\"_blank\">VRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505091-vertex-pharma-sees-2014-revenues-below-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex Pharma sees 2014 revenues below estimates</a></h4><ul>\n<li>Vertex Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/VRTX\" title=\"Vertex Pharmaceuticals Incorporated\">VRTX</a> <font color=\"red\">-1.6%</font>) is out with financial guidance ahead of its presentation at the JPMorgan Healthcare Conference on Tuesday.</li>\n<li>Cash and equivalents as of FY13 end: $1.47B.</li>\n<li>\n<em>FY14 revenues seen at $570-600M versus consensus of $659.93B</em>.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/search?query=kalydeco\" target=\"_blank\">Kalydeco</a> net revenues for FY14 projected at: $470-500M.</li>\n<li>2014 projected opex: $900-950M. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505091\" data-linked=\"Vertex Pharma sees 2014 revenues below estimates\" data-tweet=\"$VRTX - Vertex Pharma sees 2014 revenues below estimates https://seekingalpha.com/news/1505091-vertex-pharma-sees-2014-revenues-below-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/1505091-vertex-pharma-sees-2014-revenues-below-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505051\" data-ts=\"1389644594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCYC\" target=\"_blank\">PCYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505051-pharmacyclics-falls-after-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pharmacyclics falls after presentation</a></h4><ul>\n<li>Shares of Pharmacyclics (<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a> <font color=\"red\">-1.6%</font>) are lower in afternoon trading after the company's presentation at the JPMorgan Healthcare Conference.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/search?query=ibrutinib\" target=\"_blank\">Ibrutinib</a> highlights from the <a href=\"https://twitter.com/BMTEdny/status/422819097068331008/photo/1\" target=\"_blank\">\"conclusions\" slide</a>: Drug \"demonstrated safety, tolerability, and durability of response at \u2265 one year ... in treatment naive and relapsed/refractory CLL/SLL;\" serious AEs decreased after one year of treatment; median DOR not yet reached in extension study.</li>\n<li>See also: <a href=\"http://www.sec.gov/Archives/edgar/data/949699/000138713114000124/pcyc-8k_011314.htm\" target=\"_blank\">PCYC notifies investors of relevant changes to NCCN Clinical Practice Guidelines </a>\n</li>\n<li>For more on ibrutinib (Imbruvica) in CLL/SLL, see <a href=\"https://seekingalpha.com/news/1495181-imbruvica-continues-to-impress-as-phase-3-study-stopped-early\" target=\"_blank\">here</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505051\" data-linked=\"Pharmacyclics falls after presentation\" data-tweet=\"$PCYC - Pharmacyclics falls after presentation https://seekingalpha.com/news/1505051-pharmacyclics-falls-after-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/1505051-pharmacyclics-falls-after-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505041\" data-ts=\"1389644028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVR\" target=\"_blank\">PVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505041-pvr-partners-says-eastern-midstreams-december-throughput-plus-60-percent-y-y\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PVR Partners says Eastern Midstream&#39;s December throughput +60% Y/Y</a></h4><ul>     <li>In an <a href=\"http://finance.yahoo.com/news/pvr-partners-l-p-provides-130000392.html\" target=\"_blank\">operational update</a> of its Marcellus shale activity, PVR Partners (<a href=\"https://seekingalpha.com/symbol/PVR\" title=\"Penn Virginia Resource Partners, L.P.\">PVR</a> <font color=\"green\">+1.7%</font>) says total throughput for its Eastern Midstream Segment averaged more than 1.8B cf/day during December, up 60% Y/Y, and PVR completed 101 well connections in the segment during FY 2013.</li>     <li>PVR also says it entered into an agreement to provide transportation and related services to a major Marcellus Shale natural gas producer, which has committed to 50M cf/day of firm natural gas transportation on PVR's Wyoming trunkline.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1505041\" data-linked=\"PVR Partners says Eastern Midstream&#39;s December throughput +60% Y/Y\" data-tweet=\"$PVR - PVR Partners says Eastern Midstream&#39;s December throughput +60% Y/Y https://seekingalpha.com/news/1505041-pvr-partners-says-eastern-midstreams-december-throughput-plus-60-percent-y-y?source=tweet\" data-url=\"https://seekingalpha.com/news/1505041-pvr-partners-says-eastern-midstreams-december-throughput-plus-60-percent-y-y\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1505021\" data-ts=\"1389643681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1505021-broad-market-slump-boosts-mreits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broad market slump boosts mREITs</a></h4><ul>\n<li>What might pull the mREIT sector out of its brutal slump? A slide in the broad equity market for one. An out of nowhere 1%-plus dive in the major averages is being felt in the bond market, where the 10-year yield is off another 3 basis points to 2.83%, and mortgage REITs (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"green\">+0.4%</font>) - whose book values have been savaged by the big jump in interest rates since last spring - are responding.</li>\n<li>Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"green\">+1.2%</font>), American Capital (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"green\">+1.4%</font>), (<a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a> <font color=\"green\">+1.1%</font>), Two Harbors (<a href=\"https://seekingalpha.com/symbol/TWO\" title=\"Two Harbors Investment Corp.\">TWO</a> <font color=\"green\">+1.4%</font>), CYS (<a href=\"https://seekingalpha.com/symbol/CYS\" title=\"CYS Investments, Inc.\">CYS</a> <font color=\"green\">+1.9%</font>), Western Asset (<a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"green\">+1.5%</font>), AG Mortgage (<a href=\"https://seekingalpha.com/symbol/MITT\" title=\"AG Mortgage Investment Trust, Inc.\">MITT</a> <font color=\"green\">+1.1%</font>), and Ellington Residential (<a href=\"https://seekingalpha.com/symbol/EARN\" title=\"Ellington Residential Mortgage REIT\">EARN</a> <font color=\"green\">+0.8%</font>) are leading. This just in: Sector giants American Capital Agency and Annaly are <font color=\"green\">ahead 6%</font> and <font color=\"green\">4%</font> YTD, respectively.</li>\n<li>The iShares 20+ Year Treasury Bond ETF (<a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.6%</font>) is <font color=\"green\">up 3.2%</font> for the year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1505021\" data-linked=\"Broad market slump boosts mREITs\" data-tweet=\"$NLY $REM $NLY - Broad market slump boosts mREITs https://seekingalpha.com/news/1505021-broad-market-slump-boosts-mreits?source=tweet\" data-url=\"https://seekingalpha.com/news/1505021-broad-market-slump-boosts-mreits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504971\" data-ts=\"1389642162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504971-ladenburg-thalmann-assumes-bullish-coverage-of-oxygen-biotherapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ladenburg Thalmann assumes bullish coverage of Oxygen Biotherapeutics</a></h4><ul>\n<li>Oxygen Biotherapeutics (OXBT <font color=\"green\">+13.1%</font>) posts double-digit gains on heavy volume.</li>\n<li>Ladenburg Thalmann has <a href=\"http://www.streetinsider.com/news.php?id=9048843\" target=\"_blank\">initiated coverage</a> at Buy.</li>\n<li>Price target is $10.50, representing upside of <font color=\"green\">~43%</font> from Friday's close.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504971\" data-linked=\"Ladenburg Thalmann assumes bullish coverage of Oxygen Biotherapeutics\" data-tweet=\"$TENX - Ladenburg Thalmann assumes bullish coverage of Oxygen Biotherapeutics https://seekingalpha.com/news/1504971-ladenburg-thalmann-assumes-bullish-coverage-of-oxygen-biotherapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/1504971-ladenburg-thalmann-assumes-bullish-coverage-of-oxygen-biotherapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504921\" data-ts=\"1389641120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504921-galectin-therapeutics-falls-after-big-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin Therapeutics falls after big rally</a></h4><ul>\n<li>Galectin Therapeutics (<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"red\">-13.9%</font>) is having a rough session.</li>\n<li>The <a href=\"https://seekingalpha.com/news/1501771-galectin-extends-rally-as-company-discloses-share-sales\" target=\"_blank\">shares rose</a> <font color=\"green\">76%</font> late last week, as investors clamored for liver disease plays in the wake of Intercept Pharmaceuticals' monumental rally.</li>\n<li>Today, the company announced the completion of patient enrollment \"in the first cohort of a Phase 1 trial of GR-MD-02.\"</li>\n<li>The study will evaluate the \"safety, tolerability, and exploratory biomarkers for efficacy for  single and multiple doses of GR-MD-02 when administered to patients with  fatty liver disease with advanced fibrosis.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504921\" data-linked=\"Galectin Therapeutics falls after big rally\" data-tweet=\"$GALT - Galectin Therapeutics falls after big rally https://seekingalpha.com/news/1504921-galectin-therapeutics-falls-after-big-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1504921-galectin-therapeutics-falls-after-big-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504901\" data-ts=\"1389640709\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504901-fbr-still-bullish-on-mckesson-following-celesio-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FBR still bullish on McKesson following Celesio news</a></h4><ul><li>\"We naturally expected shares would decline following the disappointing news,\" FBR's Tom Gallucci says of McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='red'>-4.8%</font>), in the wake of the company's <a href=\"https://seekingalpha.com/news/1504741-mckesson-reports-failed-bid-for-celesio\" target=\"_blank\">failed bid</a> for Celesio (<a href='https://seekingalpha.com/symbol/CAKFF' title='McKesson Europe AG'>OTCPK:CAKFF</a>).</li><li>Nevertheless, Gallucci says MCK is \"<a href=\"http://www.streetinsider.com/Analyst+Comments/Celesio+News+Disappointing+for+McKesson+%28MCK%29%2C+But+Not+the+End+All%2C+Be+All+-+FBR/9049732.html\" target=\"_blank\">well positioned going forward</a> [as] the company's core operations have been the best performing in the sector over the past year.\"</li><li>Outperform rating maintained.</li></ul><div class=\"tiny-share-widget\" data-id=\"1504901\" data-linked=\"FBR still bullish on McKesson following Celesio news\" data-tweet=\"$MCK $MCK $CAKFF - FBR still bullish on McKesson following Celesio news https://seekingalpha.com/news/1504901-fbr-still-bullish-on-mckesson-following-celesio-news?source=tweet\" data-url=\"https://seekingalpha.com/news/1504901-fbr-still-bullish-on-mckesson-following-celesio-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504881\" data-ts=\"1389639828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTK\" target=\"_blank\">CYTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504881-cytokinetics-updates-omecamtiv-mecarbil-program-shares-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytokinetics updates omecamtiv mecarbil program, shares fall</a></h4><ul>\n<li>Cytokinetics (<a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"red\">-7.9%</font>) is lower on the day after giving an update on the development of <a href=\"https://seekingalpha.com/news/search?query=omecamtiv+mecarbil\" target=\"_blank\">omecamtiv mecarbil</a>.</li>\n<li>CYTK says that it and partner Amgen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>) have \"agreed to amend the protocol to evaluate a dose titration strategy in the expansion phase of COSMIC-HF [and up] the size of the expansion phase ... with the objective to provide greater statistical power for the planned  evaluation of several pharmacodynamic parameters during oral dosing.\" (PR)</li>\n<li>Here's <em>The Street</em>'s Adam Feuerstein, <a href=\"https://twitter.com/adamfeuerstein/status/422709201077424128\" target=\"_blank\">commenting</a>: \"Sounds like data release will be pushed back.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504881\" data-linked=\"Cytokinetics updates omecamtiv mecarbil program, shares fall\" data-tweet=\"$CYTK $CYTK $AMGN - Cytokinetics updates omecamtiv mecarbil program, shares fall https://seekingalpha.com/news/1504881-cytokinetics-updates-omecamtiv-mecarbil-program-shares-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/1504881-cytokinetics-updates-omecamtiv-mecarbil-program-shares-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504871\" data-ts=\"1389639783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLGNF\" target=\"_blank\">DLGNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504871-apple-cirrus-logic-rally-after-iphone-ipad-supplier-reports-strong-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple, Cirrus Logic rally after iPhone/iPad supplier reports strong sales</a></h4><ul>\n<li>iPhone/iPad power management IC supplier Dialog Semi (<a href=\"https://seekingalpha.com/symbol/DLGNF\" title=\"Dialog Semiconductor Plc\">OTCPK:DLGNF</a>), which receives over 70% of its sales from Apple (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"green\">+1.2%</font>), has reported <a href=\"http://www.businesswire.com/news/home/20140113005666/en/Dialog-Semiconductor-Reports-Record-Revenue-Q4-2013#.UtQ1Up57vh4\" target=\"_blank\">preliminary Q4 revenue</a> of $352M (+31% Y/Y). That handily beats prior guidance of $310M, which itself was above a previous forecast of $270M-$295M. Shares <font color=\"green\">rose 7.4%</font> in Frankfurt.</li>\n<li>Apple is trading higher following Dialog's announcement, as is Cirrus Logic (<a href=\"https://seekingalpha.com/symbol/CRUS\" title=\"Cirrus Logic, Inc.\">CRUS</a> <font color=\"green\">+2.8%</font>), a chipmaker just as dependent on Apple as Dialog.</li>\n<li>Dialog's numbers are overshadowing <a href=\"https://twitter.com/thenotablecalls/status/422737762458927104\" target=\"_blank\">a downbeat note</a> from Cleveland Research regarding early China Mobile (<a href=\"https://seekingalpha.com/symbol/CHL\" title=\"China Mobile Limited\">CHL</a> <font color=\"red\">-0.8%</font>) iPhone demand. Cleveland says its checks point to disappointing China Mobile pre-registrations, and lead it to think the carrier will sell only 10M iPhones in 2014 (below peer estimates of 15M-30M).</li>\n<li>\n<a href=\"https://seekingalpha.com/news/1486151-wedge-partners-offers-cautious-china-mobile-iphone-estimates\" target=\"_blank\">Wedge Partners</a> has also provided cautious commentary about China Mobile's iPhone pre-registrations. The world's biggest carrier begins selling the iPhone on Friday.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504871\" data-linked=\"Apple, Cirrus Logic rally after iPhone/iPad supplier reports strong sales\" data-tweet=\"$DLGNF $DLGNF $AAPL - Apple, Cirrus Logic rally after iPhone/iPad supplier reports strong sales https://seekingalpha.com/news/1504871-apple-cirrus-logic-rally-after-iphone-ipad-supplier-reports-strong-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/1504871-apple-cirrus-logic-rally-after-iphone-ipad-supplier-reports-strong-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504831\" data-ts=\"1389638781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIVO\" target=\"_blank\">TIVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504831-tivo-falls-on-goldman-downgrade-margins-deal-opportunities-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TiVo falls on Goldman downgrade; margins, deal opportunities in focus</a></h4><ul>\n<li>Goldman's <a href=\"http://www.streetinsider.com/Hot+Downgrades/Goldman+Sachs+Downgrades+TiVo+%28TIVO%29+to+Neutral%3B+Sees+Limited+Upside/9047399.html\" target=\"_blank\">Heather Bellini</a> has cut TiVo (<a href=\"https://seekingalpha.com/symbol/TIVO\" title=\"TiVo Inc.\">TIVO</a> <font color=\"red\">-3.8%</font>) to Neutral, and lowered her PT to $14.50 from $16. She's worried about a dearth of new cable deal opportunities, and expects EBITDA margins (exc. licensing settlement payments) to be pressured by \"[subscriber] growth challenges.\"</li>\n<li>Bellini's FY15 (ends Jan. '15) EBITDA forecast has been lowered to $102M from $105M (consensus is at $115M), and her FY14-16 EPS estimates have also been cut.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504831\" data-linked=\"TiVo falls on Goldman downgrade; margins, deal opportunities in focus\" data-tweet=\"$TIVO - TiVo falls on Goldman downgrade; margins, deal opportunities in focus https://seekingalpha.com/news/1504831-tivo-falls-on-goldman-downgrade-margins-deal-opportunities-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1504831-tivo-falls-on-goldman-downgrade-margins-deal-opportunities-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504771\" data-ts=\"1389636878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRNT\" target=\"_blank\">CRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504771-ceragon-soars-after-announcing-4g-backhaul-hardware-orders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ceragon soars after announcing 4G backhaul hardware orders</a></h4><ul>\n<li>Ceragon (<a href=\"https://seekingalpha.com/symbol/CRNT\" title=\"Ceragon Networks Ltd.\">CRNT</a> <font color=\"green\">+14.2%</font>) has received orders for its <a href=\"http://www.ceragon.com/us/products-ceragon/packet-hybrid-microwave\" target=\"_blank\">FibeAir</a> mobile backhaul hardware from unnamed \"leading national operators in North America and India,\" for use in their 4G rollouts. Shares have jumped to levels last seen in late October. (PR)</li>\n<li>Ceragon will \"deploy hundreds of radio links\" for the North American carrier, via its FibeAir IP-20A backhaul aggregation node. The India carrier will deploy Ceragon's IP-20N aggregation node and IP-20C backhaul transmission system.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504771\" data-linked=\"Ceragon soars after announcing 4G backhaul hardware orders\" data-tweet=\"$CRNT - Ceragon soars after announcing 4G backhaul hardware orders https://seekingalpha.com/news/1504771-ceragon-soars-after-announcing-4g-backhaul-hardware-orders?source=tweet\" data-url=\"https://seekingalpha.com/news/1504771-ceragon-soars-after-announcing-4g-backhaul-hardware-orders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504761\" data-ts=\"1389636243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504761-mckesson-down-6_7-percent-after-celesio-bid-fails\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McKesson down 6.7% after Celesio bid fails</a></h4><ul>\n<li>Reopened for trade, McKesson (<a href=\"https://seekingalpha.com/symbol/MCK\" title=\"McKesson Corporation\">MCK</a> <font color=\"red\">-6.7%</font>) gives back about all of last week's gains following<a href=\"https://seekingalpha.com/news/1504741\" target=\"_blank\"> its failed bid</a> for Celesio (<a href=\"https://seekingalpha.com/symbol/CAKFF\" title=\"McKesson Europe AG\">OTCPK:CAKFF</a> <font color=\"red\">-1%</font>).</li>\n<li>CEO John Hammergren: \"We are well positioned and will continue to explore and evaluate opportunities to further strengthen our businesses through our disciplined approach to capital allocation.\u201d</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504761\" data-linked=\"McKesson down 6.7% after Celesio bid fails\" data-tweet=\"$MCK $MCK $CAKFF - McKesson down 6.7% after Celesio bid fails https://seekingalpha.com/news/1504761-mckesson-down-6_7-percent-after-celesio-bid-fails?source=tweet\" data-url=\"https://seekingalpha.com/news/1504761-mckesson-down-6_7-percent-after-celesio-bid-fails\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504741\" data-ts=\"1389635971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAKFF\" target=\"_blank\">CAKFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504741-mckesson-reports-failed-bid-for-celesio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McKesson reports failed bid for Celesio</a></h4><ul><li>Despite its<a href=\"https://seekingalpha.com/news/1499181\" target=\"_blank\"> raised bid</a> for Celesio (<a href=\"https://seekingalpha.com/symbol/CAKFF\" title=\"McKesson Europe AG\">OTCPK:CAKFF</a> <font color=\"green\">+3.3%</font>), McKesson (<a href=\"https://seekingalpha.com/symbol/MCK\" title=\"McKesson Corporation\">MCK</a> <font color=\"red\">-1.1%</font>) is unable to get the necessary 75% shareholder support. McKesson shares are currently under trading halt.</li></ul><div class=\"tiny-share-widget\" data-id=\"1504741\" data-linked=\"McKesson reports failed bid for Celesio\" data-tweet=\"$CAKFF $CAKFF $MCK - McKesson reports failed bid for Celesio https://seekingalpha.com/news/1504741-mckesson-reports-failed-bid-for-celesio?source=tweet\" data-url=\"https://seekingalpha.com/news/1504741-mckesson-reports-failed-bid-for-celesio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504721\" data-ts=\"1389635545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIGM\" target=\"_blank\">SIGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504721-sigma-designs-jumps-following-bullish-sa-pro-column\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sigma Designs jumps following bullish SA Pro column</a></h4><ul>\n<li>In an SA Pro column (embargoed until 11AM ET Tuesday), <a href=\"https://seekingalpha.com/article/1942091-sigma-designs-appealing-at-2x-cash-with-catalysts-impending\" target=\"_blank\">Nassarius Capital </a>asserts Sigma Designs (<a href=\"https://seekingalpha.com/symbol/SIGM\" title=\"Sigma Designs, Inc.\">SIGM</a> <font color=\"green\">+2.9%</font>) could more than double from current levels.</li>\n<li>The author notes shares trade at only 2x cash (limits downside), and sees Sigma's <a href=\"https://seekingalpha.com/news/1081282\" target=\"_blank\">restructuring efforts</a> and the presence of activist investor <a href=\"https://seekingalpha.com/instablog/10572281-secfilings-com/1724901-raging-capital-pushes-for-changes-at-sigma-designs\" target=\"_blank\">Raging Capital</a> acting as catalysts.</li>\n<li>Another activist firm, Potomac Capital, recently unloaded its Sigma position. In tandem with the move, Potomac manager Eric Singer resigned as Sigma's chairman.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504721\" data-linked=\"Sigma Designs jumps following bullish SA Pro column\" data-tweet=\"$SIGM - Sigma Designs jumps following bullish SA Pro column https://seekingalpha.com/news/1504721-sigma-designs-jumps-following-bullish-sa-pro-column?source=tweet\" data-url=\"https://seekingalpha.com/news/1504721-sigma-designs-jumps-following-bullish-sa-pro-column\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504711\" data-ts=\"1389635443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504711-energy-transfer-equity-price-target-raised-to-100-103-at-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer Equity price target raised to $100-$103 at Wells Fargo</a></h4><ul>     <li>Energy Transfer Equity (ETE <font color=\"green\">+2.1%</font>) is maintained at Outperform but with a <a href=\"http://www.streetinsider.com/Analyst+Comments/Energy+Transfer+Equity+%28ETE%29+PT+Raised+to+%24100-%24103+at+Wells+Fargo/9049269.html\" target=\"_blank\">higher price target of $100-$103</a> vs. an earlier $83-$86 by Wells Fargo, which sees upside from ETE's proposed liquefied natural gas-focused MLP.</li>     <li>The firm estimates ETE\u2019s interest in the new MLP could represent $28-$32/unit of value; although ETE was one of the best performing MLPs in 2013, the firm thinks upside potential from the LNG export opportunity is not fully reflected in the current valuation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504711\" data-linked=\"Energy Transfer Equity price target raised to $100-$103 at Wells Fargo\" data-tweet=\"$ET - Energy Transfer Equity price target raised to $100-$103 at Wells Fargo https://seekingalpha.com/news/1504711-energy-transfer-equity-price-target-raised-to-100-103-at-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/1504711-energy-transfer-equity-price-target-raised-to-100-103-at-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504691\" data-ts=\"1389635171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504691-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Top 10 Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a> <font color=\"green\">+47%</font>. <a href=\"https://seekingalpha.com/symbol/RNN\" title=\"Rexahn Pharmaceuticals Inc\">RNN</a> <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/OGEN\" title=\"Oragenics, Inc.\">OGEN</a> <font color=\"green\">+33%</font>. <a href=\"https://seekingalpha.com/symbol/TSH\" title=\"Teche Holding Co\">TSH</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/DLHC\" title=\"DLH Holdings Corp\">DLHC</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/NPO\" title=\"EnPro Industries, Inc.\">NPO</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/BEAM\" title=\"Beam, Inc.\">BEAM</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/IDRA\" title=\"Idera Pharmaceuticals, Inc.\">IDRA</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/CKSW\" title=\"ClickSoftware Technologies Ltd.\">CKSW</a> <font color=\"green\">+23%</font>.</li>\n<li>\n<b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/GSE\" title=\"GSE Holding\">GSE</a> <font color=\"red\">-44%</font>. <a href=\"https://seekingalpha.com/symbol/SODA\" title=\"SodaStream International\">SODA</a> <font color=\"red\">-22%</font>. <a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/PGEM\" title=\"Ply Gem Holdings\">PGEM</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CORT\" title=\"Corcept Therapeutics Incorporated\">CORT</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CNYD\" title=\"China Yida Holding, Co.\">CNYD</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/BONT\" title=\"The Bon-Ton Stores, Inc.\">OTC:BONT</a> <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504691\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ALNY $REXN $OGEN - Midday Gainers / Losers https://seekingalpha.com/news/1504691-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1504691-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504631\" data-ts=\"1389633521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSM\" target=\"_blank\">FSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504631-fortuna-silver-mines-posts-record-2013-output-forecasts-big-2014-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortuna Silver Mines posts record 2013 output, forecasts big 2014 gains</a></h4><ul>     <li>Fortuna Silver Mines (<a href=\"https://seekingalpha.com/symbol/FSM\" title=\"Fortuna Silver Mines\">FSM</a> <font color=\"green\">+8.7%</font>) surges after reporting 2013 record production of 5.9M silver equiv. oz., or 4.6M oz. of silver and ~21.2K oz. of gold from its San Jose mine in Mexico and Caylloma mine in Peru.</li>     <li>FSM expects 2014 silver production to grow by 30% to ~6M oz. and gold production to rise 51% to ~32.3K oz., or ~8M silver equiv. oz., at an all-in sustaining cash cost of  ~$17.14/oz. of silver.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504631\" data-linked=\"Fortuna Silver Mines posts record 2013 output, forecasts big 2014 gains\" data-tweet=\"$FSM - Fortuna Silver Mines posts record 2013 output, forecasts big 2014 gains https://seekingalpha.com/news/1504631-fortuna-silver-mines-posts-record-2013-output-forecasts-big-2014-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1504631-fortuna-silver-mines-posts-record-2013-output-forecasts-big-2014-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504591\" data-ts=\"1389632700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CORT\" target=\"_blank\">CORT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504591-corcept-therapeutics-falls-after-stifel-moves-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corcept Therapeutics falls after Stifel moves to sidelines</a></h4><ul>\n<li>Corcept Therapeutics (<a href=\"https://seekingalpha.com/symbol/CORT\" title=\"Corcept Therapeutics Incorporated\">CORT</a> <font color=\"red\">-14.1%</font>) is sharply lower on the session.</li>\n<li>Stifel has <a href=\"http://www.streetinsider.com/Downgrades/Stifel+Nicolaus+Downgrades+Corcept+Therapeutics+%28CORT%29+to+Hold/9048074.html\" target=\"_blank\">cut the shares</a> to Hold from Buy.</li>\n<li>$3 price target removed.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504591\" data-linked=\"Corcept Therapeutics falls after Stifel moves to sidelines\" data-tweet=\"$CORT - Corcept Therapeutics falls after Stifel moves to sidelines https://seekingalpha.com/news/1504591-corcept-therapeutics-falls-after-stifel-moves-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/1504591-corcept-therapeutics-falls-after-stifel-moves-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504571\" data-ts=\"1389632333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504571-summer-street-shrugs-off-intercept-pharma-ldl-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Summer Street shrugs off Intercept Pharma LDL concerns</a></h4><ul>\n<li>Shares of Intercept Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a> <font color=\"red\">-20.5%</font>) are off their <a href=\"https://seekingalpha.com/news/1503691-intercepts-shares-start-coming-back-down-to-earth\" target=\"_blank\">premarket lows</a>, but are still sharply lower coming off last week's improbable run.</li>\n<li>Count Summer Street's Bart Classen among those not too concerned with the <a href=\"https://seekingalpha.com/news/1503321-intercepts-oca-drug-linked-with-worsened-cholesterol-levels\" target=\"_blank\">\"bad\" cholesterol chatter</a> that's at least partly responsible for today's sell-off.<br>\n</li>\n<li>Classen reportedly thinks that due to the seriousness of NASH, a potential rise in LDL likely <a href=\"http://www.streetinsider.com/Analyst+Comments/Higher+LDL+Will+Not+Stop+Patients+from+Taking+Intercept+Pharmaceuticals%27+%28ICPT%29+OCA+-+Summer+Street/9048346.html\" target=\"_blank\">won't be enough</a> to deter many people from using OCA. </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504571\" data-linked=\"Summer Street shrugs off Intercept Pharma LDL concerns\" data-tweet=\"$ICPT - Summer Street shrugs off Intercept Pharma LDL concerns https://seekingalpha.com/news/1504571-summer-street-shrugs-off-intercept-pharma-ldl-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/1504571-summer-street-shrugs-off-intercept-pharma-ldl-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504501\" data-ts=\"1389631725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTK\" target=\"_blank\">RTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504501-rentech-plus-5_6-percent-as-shareholder-group-seeks-board-nominees\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rentech +5.6% as shareholder group seeks board nominees</a></h4><ul>     <li>A group led by Engaged Capital, Lone Star Value Management and a major shareholder says it has <a href=\"http://finance.yahoo.com/news/concerned-rentech-shareholders-seeks-reconstitute-133000895.html\" target=\"_blank\">nominated four candidates</a> for election to Rentech's (<a href='https://seekingalpha.com/symbol/RTK' title='Rentech, Inc'>RTK</a> <font color='green'>+5.6%</font>) board at the upcoming annual meeting.</li>     <li>The group highlights \"its frustration at the continued destruction of shareholder value... and the persistent missteps and lapses in oversight that have caused the group to lose confidence in the current Board's ability to effectively oversee RTK.\"</li><li><a href='https://seekingalpha.com/symbol/RNF' title='Rentech Nitrogen Partners, L.P.'>RNF</a> <font color='green'>+3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504501\" data-linked=\"Rentech +5.6% as shareholder group seeks board nominees\" data-tweet=\"$RTK $RTK $RNF - Rentech +5.6% as shareholder group seeks board nominees https://seekingalpha.com/news/1504501-rentech-plus-5_6-percent-as-shareholder-group-seeks-board-nominees?source=tweet\" data-url=\"https://seekingalpha.com/news/1504501-rentech-plus-5_6-percent-as-shareholder-group-seeks-board-nominees\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504491\" data-ts=\"1389631510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSM\" target=\"_blank\">NSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504491-nationstar-a-best-idea-short-at-hedgeye\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nationstar a &quot;Best Idea&quot; short at Hedgeye</a></h4><ul>\n<li>Nationstar Mortgage (<a href=\"https://seekingalpha.com/symbol/NSM\" title=\"Nationstar Mortgage Holdings\">NSM</a> <font color=\"green\">+3.7%</font>) won't be able to make its 2014 guidance ($3.15-$4.20 per share) for servicing operations even using management's preferred accounting treatment, says Hedgeye's Josh Steiner, making the stock one of his firm's best ideas on the short side.</li>\n<li>A bull on Nationstar about a year ago amid its big run higher, Steiner - worried about slowing origination business - cashed in his chips last fall. A focus on the servicing operations has turned him outright bearish.</li>\n<li>Is there a bull case to be made? A sharp drop in mortgage rates, says Steiner, could re-ignite mortgage originations.</li>\n<li>Off 42% since the September high, the stock is higher today <a href=\"https://seekingalpha.com/news/1503941-nationstar-raised-to-a-buy-at-sterne-agee\" target=\"_blank\">amid an upgrade</a> from Sterne Agee.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504491\" data-linked=\"Nationstar a &quot;Best Idea&quot; short at Hedgeye\" data-tweet=\"$NSM - Nationstar a &quot;Best Idea&quot; short at Hedgeye https://seekingalpha.com/news/1504491-nationstar-a-best-idea-short-at-hedgeye?source=tweet\" data-url=\"https://seekingalpha.com/news/1504491-nationstar-a-best-idea-short-at-hedgeye\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504451\" data-ts=\"1389630480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GG\" target=\"_blank\">GG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504451-goldcorp-minus-2_2-percent-on-osisko-bid-considers-malartic-mine-low-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldcorp -2.2% on Osisko bid, considers Malartic mine low-risk</a></h4><ul>     <li>The <a href=\"http://business.financialpost.com/2014/01/13/goldcorp-inc-offers-2-6-billion-for-osisko-mining/\" target=\"_blank\">big prize</a> in Goldcorp's (<a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"red\">-2.2%</font>) <a href=\"https://seekingalpha.com/news/1503601-more-on-goldcorps-2_6b-bid-for-osisko\" target=\"_blank\">proposed $2.6B bid</a> for Osisko Mining (OSKFF <font color=\"green\">+20.5%</font>) is the giant Canadian Malartic gold mine in Quebec, which is likely to produce 500K-600K oz./year of gold over its 16-year mine life.</li>     <li>Osisko had challenges ramping up production, but Goldcorp considers the mine low-risk; during a <a href=\"http://www.goldcorp.com/English/Investor-Resources/Events-and-Webcasts/EventDetails/2014/Goldcorp-Bid-for-Osisko/default.aspx\" target=\"_blank\">conference call</a> to discuss the hostile offer, GG says Malartic would be one of its leading mines in terms of free cash flow,  production and net asset value, and the mine would benefit  from GG's technical and operating expertise (Briefing.com).</li>\n<li>GG says the deal will be immediately accretive on key operating and  financial metrics, including free cash flow, operating cash flow, net  asset value, gold production and gold reserves.</li>     <li>TD Securities analyst Greg Barnes thinks a rival bid is unlikely given  that other senior gold miners are struggling with \"heavier balance  sheets and generally weaker multiples\u201d relative to Goldcorp.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504451\" data-linked=\"Goldcorp -2.2% on Osisko bid, considers Malartic mine low-risk\" data-tweet=\"$GG $GG $OBNNF - Goldcorp -2.2% on Osisko bid, considers Malartic mine low-risk https://seekingalpha.com/news/1504451-goldcorp-minus-2_2-percent-on-osisko-bid-considers-malartic-mine-low-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/1504451-goldcorp-minus-2_2-percent-on-osisko-bid-considers-malartic-mine-low-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504431\" data-ts=\"1389629556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504431-acorda-therapeutics-reports-preliminary-results-provides-2014-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda Therapeutics reports preliminary results, provides 2014 guidance</a></h4><ul>\n<li>Shares of Acorda Therapeutics (<a href=\"https://seekingalpha.com/symbol/ACOR\" title=\"Acorda Therapeutics, Inc.\">ACOR</a> <font color=\"green\">+4.2%</font>) are higher in morning trading after the company provided preliminary financial results in connection with the JPMorgan Healthcare Conference.</li>\n<li>Q4 and FY <a href=\"https://seekingalpha.com/news/search?query=ampyra\" target=\"_blank\">Ampyra</a> net sales: $84M and $302M, respectively.</li>\n<li><em>2014 Ampyra net sales guidance: $328-335M.</em></li>\n<li>2014 opex guidance: R&amp;D, $60-70M; SG&amp;A, $180-190M.</li>\n<li>2014 Zanaflex guidance and ex-U.S. Fampyra revenue: $25M</li>\n<li>PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504431\" data-linked=\"Acorda Therapeutics reports preliminary results, provides 2014 guidance\" data-tweet=\"$ACOR - Acorda Therapeutics reports preliminary results, provides 2014 guidance https://seekingalpha.com/news/1504431-acorda-therapeutics-reports-preliminary-results-provides-2014-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1504431-acorda-therapeutics-reports-preliminary-results-provides-2014-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504411\" data-ts=\"1389629064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKSW\" target=\"_blank\">CKSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504411-clicksoftware-skyrockets-after-pre-announcing-strong-q4-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ClickSoftware skyrockets after pre-announcing strong Q4 sales</a></h4><ul>\n<li>ClickSoftware (<a href=\"https://seekingalpha.com/symbol/CKSW\" title=\"ClickSoftware Technologies Ltd.\">CKSW</a> <font color=\"green\">+22.6%</font>) expects to report Q4 revenue of ~$30.5M, above prior guidance of $26M-$28M and a $26M consensus. The company also expects to post a Q4 profit (EPS consensus is at -$0.04), and says its cash/investment balance rose by $2.3M during the quarter. (PR)</li>\n<li>Shares of the field service software provider are flying higher after turning in <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1387573200000&amp;chddm=97227&amp;chls=IntervalBasedLine&amp;q=NASDAQ:CKSW&amp;ntsp=1&amp;ei=MwrUUtDxCaqziQK_3wE\" target=\"_blank\">a rough 2013</a>, thanks in large part to <a href=\"https://seekingalpha.com/news/1321492-clicksoftware-issues-q3-warning-shares-minus-11_3-percent-ah\" target=\"_blank\">bad earnings news</a> blamed on a transition to cloud/subscription-based software sales.</li>\n<li>19 customers were added in Q4 (said to be a record), over half of which made cloud-related purchases. Full Q4 results arrive on the morning of Feb. 5.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504411\" data-linked=\"ClickSoftware skyrockets after pre-announcing strong Q4 sales\" data-tweet=\"$CKSW - ClickSoftware skyrockets after pre-announcing strong Q4 sales https://seekingalpha.com/news/1504411-clicksoftware-skyrockets-after-pre-announcing-strong-q4-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/1504411-clicksoftware-skyrockets-after-pre-announcing-strong-q4-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504381\" data-ts=\"1389628720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAN\" target=\"_blank\">AAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504381-aarons-has-to-reset-expectations-after-sales-slump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aaron&#39;s has to reset expectations after sales slump</a></h4><ul> <li>Aaron's (<a href=\"https://seekingalpha.com/symbol/AAN\" title=\"Aaron's Inc.\">AAN</a> <font color=\"red\">-7.2%</font>) lowers Q4 EPS guidance to $0.27-$0.31 vs. $0.38-$0.41 prior and $0.40 consensus after seeing same-store sales turn negative during the period.</li> <li>FY14 EPS is pegged by the company at $1.80-$2.00 vs. $2.17 consensus.</li> <li>As a result of current trends, Aaron's plans to slow down the future growth track of new Aaron's and HomeSmart stores.</li> <li>PR</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504381\" data-linked=\"Aaron&#39;s has to reset expectations after sales slump\" data-tweet=\"$AAN - Aaron&#39;s has to reset expectations after sales slump https://seekingalpha.com/news/1504381-aarons-has-to-reset-expectations-after-sales-slump?source=tweet\" data-url=\"https://seekingalpha.com/news/1504381-aarons-has-to-reset-expectations-after-sales-slump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504311\" data-ts=\"1389626998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIHD\" target=\"_blank\">NIHD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504311-nii-holdings-strikes-wholesale-deal-with-telefonica-shares-soar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NII Holdings strikes wholesale deal with Telefonica, shares soar</a></h4><ul>\n<li>NII Holdings (<a href=\"https://seekingalpha.com/symbol/NIHD\" title=\"NII Holdings, Inc.\">NIHD</a> <font color=\"green\">+25.5%</font>) has struck a deal with rival Telefonica to have wholesale voice and data access to Telefonica's Brazilian and Mexican 3G networks. NII shares are taking off, while those of Telefonica's Brazilian unit, Vivo (<a href=\"https://seekingalpha.com/symbol/VIV\" title=\"Telefonica Brasil, S.A\">VIV</a> <font color=\"red\">-0.5%</font>), are down slightly. (PR)</li>\n<li>The deal allows NII to significantly expand its Brazilian/Mexican 3G coverage. The carrier has been <a href=\"https://seekingalpha.com/news/1481771-mexican-share-losses-pressure-nii-holdings-to-make-a-deal\" target=\"_blank\">struggling to halt</a> Mexican share losses, and blamed \"<a href=\"https://seekingalpha.com/news/1374372-nii-holdings-minus-20_3-percent-premarket-following-q3-miss\" target=\"_blank\">more aggressive competition</a>\" in Mexico and Brazil for its Q3 ARPU drop.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504311\" data-linked=\"NII Holdings strikes wholesale deal with Telefonica, shares soar\" data-tweet=\"$NIHD $NIHD $VIV - NII Holdings strikes wholesale deal with Telefonica, shares soar https://seekingalpha.com/news/1504311-nii-holdings-strikes-wholesale-deal-with-telefonica-shares-soar?source=tweet\" data-url=\"https://seekingalpha.com/news/1504311-nii-holdings-strikes-wholesale-deal-with-telefonica-shares-soar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504291\" data-ts=\"1389626495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504291-galena-biopharma-rises-on-acquisition-of-et-treatment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galena Biopharma rises on acquisition of ET treatment</a></h4><ul>\n<li>Galena Biopharma (GALE <font color=\"green\">+13.7%</font>) rallies on news the company is buying Mills Pharmaceuticals, giving GALE rights to GALE-401 (CR anagrelide), a treatment for Essential Thrombocythemia.</li>\n<li>In GALE's estimation, the drug \"meets the qualifications for orphan drug status [and] has an estimated peak market size of approximately $200M in the U.S.\"</li>\n<li>The company says a Phase 2 study should begin in \"mid-2014.\"</li>\n<li>GALE made an upfront payment to Mills' owners who are also eligible for stock grants and a milestone payment, the latter is contingent upon FDA approval of an NDA for '401.  (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504291\" data-linked=\"Galena Biopharma rises on acquisition of ET treatment\" data-tweet=\"$SLS - Galena Biopharma rises on acquisition of ET treatment https://seekingalpha.com/news/1504291-galena-biopharma-rises-on-acquisition-of-et-treatment?source=tweet\" data-url=\"https://seekingalpha.com/news/1504291-galena-biopharma-rises-on-acquisition-of-et-treatment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504271\" data-ts=\"1389625927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JEC\" target=\"_blank\">JEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504271-jacobs-jumps-to-five-year-highs-after-ubs-upgrade-foster-wheeler-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jacobs jumps to five-year highs after UBS upgrade, Foster Wheeler deal</a></h4><ul>     <li>Jacobs Engineering (<a href=\"https://seekingalpha.com/symbol/JEC\" title=\"Jacobs Engineering Group Inc.\">JEC</a> <font color=\"green\">+2.3%</font>) bumps to five-year highs following Amec's plan to <a href=\"https://seekingalpha.com/news/1503451-u-k-s-amec-agrees-to-buy-foster-wheeler-for-3_1b\" target=\"_blank\">acquire</a> peer engineering and construction company Foster Wheeler (FWLT <font color=\"green\">+1%</font>), and a UBS <a href=\"http://www.streetinsider.com/Upgrades/UBS+Upgrades+Jacobs+Engineering+%28JEC%29+to+Buy/9047593.html\" target=\"_blank\">upgrade</a> of JEC shares to Buy from Neutral with a $75 price target (up from $60).</li>     <li>The upgrade reflects accelerating earnings growth over  the next 12-18 months driven by acquisitions, North American energy  infrastructure, and reduced government exposure drag, UBS says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504271\" data-linked=\"Jacobs jumps to five-year highs after UBS upgrade, Foster Wheeler deal\" data-tweet=\"$JEC $J $AMFW - Jacobs jumps to five-year highs after UBS upgrade, Foster Wheeler deal https://seekingalpha.com/news/1504271-jacobs-jumps-to-five-year-highs-after-ubs-upgrade-foster-wheeler-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/1504271-jacobs-jumps-to-five-year-highs-after-ubs-upgrade-foster-wheeler-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504261\" data-ts=\"1389625803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPO\" target=\"_blank\">NPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504261-enpro-announces-liability-estimate-for-claims-against-subsidiary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EnPro announces liability estimate for claims against subsidiary</a></h4><ul>\n<li>EnPro Industries (<a href=\"https://seekingalpha.com/symbol/NPO\" title=\"EnPro Industries, Inc.\">NPO</a> <font color=\"green\">+25%</font>) rallies sharply in morning trading after announcing that the       United States Bankruptcy Court for the Western District of North       Carolina has estimated the \"liability for present and       future mesothelioma claims against EnPro's Garlock Sealing Technologies subsidiary at $125M.\"</li>\n<li>The total is consistent with the figure the company \"put forth at trial.\"</li>\n<li>\"The court has       determined that $125M is sufficient to satisfy Garlock's       liability for the legitimate present and future mesothelioma claims       against it,\" the company notes. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504261\" data-linked=\"EnPro announces liability estimate for claims against subsidiary\" data-tweet=\"$NPO - EnPro announces liability estimate for claims against subsidiary https://seekingalpha.com/news/1504261-enpro-announces-liability-estimate-for-claims-against-subsidiary?source=tweet\" data-url=\"https://seekingalpha.com/news/1504261-enpro-announces-liability-estimate-for-claims-against-subsidiary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504221\" data-ts=\"1389625008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504221-tech-ratings-change-roundup-h-p-blackberry-f5-qihoo-cree\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech ratings change roundup: H-P, BlackBerry, F5, Qihoo, Cree</a></h4><ul><li>H-P (<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a> <font color='green'>+3.7%</font>) and Teradata (<a href='https://seekingalpha.com/symbol/TDC' title='Teradata Corporation'>TDC</a> <font color='green'>+1.8%</font>) have been started at Overweight by Atlantic Securities.</li><li>BlackBerry (BBRY <font color='red'>-6.2%</font>) has been cut to Underperform by Oppenheimer following a major rally over the last four weeks. RBC upgraded shares last Friday.</li><li>F5 (<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a> <font color='green'>+3.7%</font>) has been upgraded to Outperform by William Blair.</li><li>Qihoo (<a href='https://seekingalpha.com/symbol/QIHU' title='QIHOO 360 Technology Co. Ltd.'>QIHU</a> <font color='green'>+4.3%</font>) has been upgraded to Buy by Stifel, and started at Buy by UBS. Shares <a href=\"https://seekingalpha.com/news/1500141-qihoo-tumbles-share-gains-against-baidu-may-be-smaller-than-believed\" target=\"_blank\">fell last Thursday</a> following a report questioning the size of the company's search share gains, and rose the day before thanks to an <a href=\"https://seekingalpha.com/news/1497621-qihoo-jumps-on-alibaba-investment-rumor\" target=\"_blank\">Alibaba investment rumor</a>.</li><li>Cree (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-6.6%</font>) has been cut to Hold by Stifel.</li><li>Autodesk (<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color='green'>+1.8%</font>) has been upgraded to Overweight by Morgan Stanley.</li><li>Skyworks (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='green'>+4.7%</font>) has been upgraded to Buy by B. Riley.</li><li>Red Hat (<a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color='green'>+4.4%</font>) has been upgraded to Overweight by Morgan Stanley.</li><li>Fortinet (<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a> <font color='green'>+2.1%</font>) has been upgraded to Overweight by Morgan Stanley.</li><li>HomeAway (<a href='https://seekingalpha.com/symbol/AWAY' title='HomeAway, Inc.'>AWAY</a> <font color='green'>+2%</font>) has been upgraded to Overweight by Barclays.</li><li>Garmin (<a href='https://seekingalpha.com/symbol/GRMN' title='Garmin Ltd.'>GRMN</a> <font color='green'>+1.1%</font>) has been upgraded to Outperform by Oppenheimer.</li><li>Nimble Storage (<a href='https://seekingalpha.com/symbol/NMBL' title='Nimble Storage, Inc.'>NMBL</a> <font color='green'>+2.2%</font>) has been upgraded to Outperform by Pac Crest. The firm started Nimble and Sector Perform just six days ago.</li><li>Peregrine Semi (<a href='https://seekingalpha.com/symbol/PSMI' title='Peregrine Semiconductor'>PSMI</a> <font color='red'>-9.1%</font>) has been cut to Hold by Deutsche.</li><li>Sanmina (<a href='https://seekingalpha.com/symbol/SANM' title='Sanmina Corp'>SANM</a> <font color='red'>-7%</font>) has been cut to Underperform by Raymond James.</li><li>Symantec (<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color='red'>-2.3%</font>) has been cut to Underweight by Morgan Stanley.</li><li>NCR (<a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='green'>+2.2%</font>) has been started at Overweight by JPMorgan, and added to the firm's Focus List.</li><li>Vipshop (<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color='green'>+1.8%</font>) has been started at Buy by UBS.</li><li>Parametric Sound (PAMT <font color='green'>+4.5%</font>) has been started at Strong Buy by Needham.</li></ul><div class=\"tiny-share-widget\" data-id=\"1504221\" data-linked=\"Tech ratings change roundup: H-P, BlackBerry, F5, Qihoo, Cree\" data-tweet=\"$HPQ $HPQ $TDC - Tech ratings change roundup: H-P, BlackBerry, F5, Qihoo, Cree https://seekingalpha.com/news/1504221-tech-ratings-change-roundup-h-p-blackberry-f5-qihoo-cree?source=tweet\" data-url=\"https://seekingalpha.com/news/1504221-tech-ratings-change-roundup-h-p-blackberry-f5-qihoo-cree\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504211\" data-ts=\"1389624797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SODA\" target=\"_blank\">SODA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504211-stunning-fall-for-sodastream-after-cracks-emerge-in-growth-story\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stunning fall for SodaStream after cracks emerge in growth story</a></h4><ul> <li>SodaStream (<a href=\"https://seekingalpha.com/symbol/SODA\" title=\"SodaStream International\">SODA</a> <font color=\"red\">-21.2%</font>) dives after the company put a major dent in its growth story with a lowering of guidance for its 2013 fiscal year.</li> <li>Investors seem most alarmed by the company's <a href=\"https://seekingalpha.com/news/1503701-sodastream-disappoints-in-q4-shares-minus-11_8-percent-early\" target=\"_blank\">admission</a> that it had to push through lower sell-in prices in order to push up the volume of sales. It raises the question of saturation in key markets for SodaStream's products to some beverage industry watchers.</li> <li>Shares of SODA are below $40 for the first time since 2012.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1504211\" data-linked=\"Stunning fall for SodaStream after cracks emerge in growth story\" data-tweet=\"$SODA - Stunning fall for SodaStream after cracks emerge in growth story https://seekingalpha.com/news/1504211-stunning-fall-for-sodastream-after-cracks-emerge-in-growth-story?source=tweet\" data-url=\"https://seekingalpha.com/news/1504211-stunning-fall-for-sodastream-after-cracks-emerge-in-growth-story\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504201\" data-ts=\"1389624782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOG\" target=\"_blank\">GLOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504201-gaslog-plus-2_6-percent-after-revealing-plans-for-mlp-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GasLog +2.6% after revealing plans for MLP IPO</a></h4><ul>     <li>GasLog (<a href=\"https://seekingalpha.com/symbol/GLOG\" title=\"GasLog\">GLOG</a> <font color=\"green\">+2.6%</font>) announces plans for an IPO of units in a master limited partnership to be formed to own certain of GLOG's carriers with multi-year charters.</li>     <li>The proceeds of the offering would be used primarily to reduce indebtedness.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504201\" data-linked=\"GasLog +2.6% after revealing plans for MLP IPO\" data-tweet=\"$GLOG - GasLog +2.6% after revealing plans for MLP IPO https://seekingalpha.com/news/1504201-gaslog-plus-2_6-percent-after-revealing-plans-for-mlp-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/1504201-gaslog-plus-2_6-percent-after-revealing-plans-for-mlp-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504191\" data-ts=\"1389624488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504191-first-iluvien-orders-shipped-to-u-k\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Iluvien orders shipped to U.K.</a></h4><ul>\n<li>Alimera Sciences (<a href=\"https://seekingalpha.com/symbol/ALIM\" title=\"Alimera Sciences, Inc.\">ALIM</a> <font color=\"green\">+13.5%</font>) says it has begun shipping the first orders of <a href=\"https://seekingalpha.com/news/search?query=iluvien\" target=\"_blank\">Iluvien</a> to U.K. NHS facilities.</li>\n<li>The company also says \"the first NHS patient received an implant for the treatment of DME\" on January 10.</li>\n<li>For reference: NICE guidance allows for patients with a pseudophakic eye to receive Iluvien when their chronic DME is \"considered insufficiently responsive to available therapies.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504191\" data-linked=\"First Iluvien orders shipped to U.K.\" data-tweet=\"$ALIM $EYPT - First Iluvien orders shipped to U.K. https://seekingalpha.com/news/1504191-first-iluvien-orders-shipped-to-u-k?source=tweet\" data-url=\"https://seekingalpha.com/news/1504191-first-iluvien-orders-shipped-to-u-k\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504161\" data-ts=\"1389623607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504161-yen-surges-against-dollar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yen surges against dollar</a></h4><ul>\n<li>The very crowded short Japanese yen trade continues to unwind (<a href=\"http://finviz.com/forex_charts.ashx?t=USDJPY&amp;tf=d1\" target=\"_blank\">just a bit</a>). Dollar/yen is <font color=\"red\">down 1%</font> to ¥103.13 in morning action. The pair had risen to nearly ¥106 on the year's first trading session. <a href=\"https://seekingalpha.com/symbol/fxy\" title=\"CurrencyShares Japanese Yen Trust ETF\">FXY</a> <font color=\"green\">+0.9%</font>.</li>\n<li>Nikkei futures <font color=\"red\">-1.8%</font>. <a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a> <font color=\"red\">-1.4%</font>.</li>\n<li>Related ETFs: <a href=\"https://seekingalpha.com/symbol/dxj\" title=\"WisdomTree Japan Hedged Equity ETF\">DXJ</a>, <a href=\"https://seekingalpha.com/symbol/ewj\" title=\"iShares MSCI Japan ETF\">EWJ</a>, <a href=\"https://seekingalpha.com/symbol/fxy\" title=\"CurrencyShares Japanese Yen Trust ETF\">FXY</a>, <a href=\"https://seekingalpha.com/symbol/ycs\" title=\"ProShares UltraShort Yen ETF\">YCS</a>, <a href=\"https://seekingalpha.com/symbol/jgbs\" title=\"PowerShares DB Inverse Japanese Govt. Bond Futures ETN\">JGBS</a>, <a href=\"https://seekingalpha.com/symbol/jgbd\" title=\"PowerShares DB 3x Inverse Japanese Govt. Bond Futures ETN\">JGBD</a>, <a href=\"https://seekingalpha.com/symbol/dfj\" title=\"WisdomTree Japan SmallCap Dividend ETF\">DFJ</a>, <a href=\"https://seekingalpha.com/symbol/jyn\" title=\"iPath JPY/USD Exchange Rate ETN\">JYN</a>, <a href=\"https://seekingalpha.com/symbol/nky\" title=\"Precidian MAXIS Nikkei 225 Index ETF\">NKY</a>, <a href=\"https://seekingalpha.com/symbol/dbjp\" title=\" db X-trackers MSCI Japan Hedged Equity Fund ETF\">DBJP</a>, <a href=\"https://seekingalpha.com/symbol/ezj\" title=\"ProShares Ultra MSCI Japan ETF\">EZJ</a>, <a href=\"https://seekingalpha.com/symbol/ewv\" title=\"ProShares UltraShort MSCI Japan ETF\">EWV</a>, <a href=\"https://seekingalpha.com/symbol/ycl\" title=\"ProShares Ultra Yen ETF\">YCL</a>, <a href=\"https://seekingalpha.com/symbol/scj\" title=\"iShares MSCI Japan Small-Cap ETF\">SCJ</a>, <a href=\"https://seekingalpha.com/symbol/dxjs\" title=\"WisdomTree Japan Hedged SmallCap Equity ETF\">DXJS</a>, <a href=\"https://seekingalpha.com/symbol/jsc\" title=\"SPDR Russell/Nomura Small Cap Japan ETF\">JSC</a>, <a href=\"https://seekingalpha.com/symbol/itf\" title=\"iShares Japan Large-Cap ETF\">ITF</a>, <a href=\"https://seekingalpha.com/symbol/jgbl\" title=\"PowerShares DB Japanese Government Bond Futures ETN\">JGBL</a>, <a href=\"https://seekingalpha.com/symbol/jpp\" title=\"SPDR Russell/Nomura PRIME Japan ETF\">JPP</a>, <a href=\"https://seekingalpha.com/symbol/jpnl\" title=\"Direxion Daily Japan Bull 3x Shares ETF\">JPNL</a>, <a href=\"https://seekingalpha.com/symbol/jgbt\" title=\"PowerShares DB 3x Japanese Government Bond Futures ETN\">JGBT</a>, <a href=\"https://seekingalpha.com/symbol/jpns\" title=\"Direxion Daily Japan Bear 3x Shares ETF\">JPNS</a>, <a href=\"https://seekingalpha.com/symbol/fjp\" title=\"First Trust Japan AlphaDEX ETF\">FJP</a>, <a href=\"https://seekingalpha.com/symbol/jgbb\" title=\"WisdomTree Japan Interest Rate Strategy ETF\">JGBB</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504161\" data-linked=\"Yen surges against dollar\" data-tweet=\"$FXY $DXJ $EWJ - Yen surges against dollar https://seekingalpha.com/news/1504161-yen-surges-against-dollar?source=tweet\" data-url=\"https://seekingalpha.com/news/1504161-yen-surges-against-dollar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504111\" data-ts=\"1389622879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504111-lexicon-ceo-to-leave-to-cut-almost-half-of-staff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon CEO to leave, to cut almost half of staff</a></h4><ul>   <li>Lexicon Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LXRX\" title=\"Lexicon Pharmaceuticals, Inc.\">LXRX</a>) <font color=\"red\">sinks 10.5%</font> premarket after saying that CEO Arthur Sands is leaving and that it will cut 115 jobs, or <a href=\"http://www.reuters.com/article/2014/01/13/lexicon-jobs-idUSL3N0KN2N320140113\" target=\"_blank\">45% of its workforce</a>, with the layoffs coming mainly in R&amp;D.</li>    <li>The move will save $14M for the rest of this year and $22M annually after that.</li>    <li>Lexicon is shifting its focus from drug discovery to completing the trials of therapies that are in late-stage development.</li>    <li>The company will now mainly concentrate on treatments for diabetes and carcinoid syndrome, which affects patients with a rare cancerous tumor.</li>    <li>The cost cuts come after Lexicon said last month that its irritable bowel syndrome medicine failed in Phase III testing.</li>\n<li>\"Lexicon \"essentially acknowledged that a promised partnership for the diabetes drug LX4211 isn't happening, forcing the company to move the drug into phase III studies on its own,\" writes Adam Feuerstein. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504111\" data-linked=\"Lexicon CEO to leave, to cut almost half of staff\" data-tweet=\"$LXRX - Lexicon CEO to leave, to cut almost half of staff https://seekingalpha.com/news/1504111-lexicon-ceo-to-leave-to-cut-almost-half-of-staff?source=tweet\" data-url=\"https://seekingalpha.com/news/1504111-lexicon-ceo-to-leave-to-cut-almost-half-of-staff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504081\" data-ts=\"1389622422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVNR\" target=\"_blank\">AVNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504081-avanir-pharma-reports-preliminary-financial-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avanir Pharma reports preliminary financial results</a></h4><ul>\n<li>Avanir Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AVNR\" title=\"Avanir Pharmaceuticals, Inc\">AVNR</a>) is out with preliminary results for FQ1.</li>\n<li>Non-GAAP revenue: $34.6M. Consensus is $24.15M.</li>\n<li>\n<em>Nuedexta revenue: $31.3M</em> (+13% Q/Q).</li>\n<li>Cash and equivalents of $46.5M. (PR)</li>\n<li>AVNR <font color=\"green\">+7%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504081\" data-linked=\"Avanir Pharma reports preliminary financial results\" data-tweet=\"$AVNR - Avanir Pharma reports preliminary financial results https://seekingalpha.com/news/1504081-avanir-pharma-reports-preliminary-financial-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1504081-avanir-pharma-reports-preliminary-financial-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504071\" data-ts=\"1389622347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504071-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a> <font color=\"green\">+35%</font>. <a href=\"https://seekingalpha.com/symbol/NPO\" title=\"EnPro Industries, Inc.\">NPO</a> <font color=\"green\">+33%</font>. <a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/BEAM\" title=\"Beam, Inc.\">BEAM</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/NIHD\" title=\"NII Holdings, Inc.\">NIHD</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/RNN\" title=\"Rexahn Pharmaceuticals Inc\">RNN</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/XGTI\" title=\"xG Technology, Inc.\">XGTI</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/DNDN\" title=\"Dendreon Corporation\">DNDN</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/XNPT\" title=\"XenoPort, Inc.\">XNPT</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/GSE\" title=\"GSE Holding\">GSE</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/SODA\" title=\"SodaStream International\">SODA</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/RNA\" title=\"Prosensa Holding N.V.\">RNA</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/ASNA\" title=\"Ascena Retail Group Inc\">ASNA</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/LXRX\" title=\"Lexicon Pharmaceuticals, Inc.\">LXRX</a> <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1504071\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$ROSG-OLD $NPO $ALNY - Premarket Gainers / Losers https://seekingalpha.com/news/1504071-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1504071-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504061\" data-ts=\"1389622344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504061-elliott-management-obtains-juniper-stake-shares-plus-5_5-percent-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott Management obtains Juniper stake, shares +5.5% premarket</a></h4><ul>\n<li>Activist investor Elliott Management has obtained a 6.2% stake in Juniper (NYSE:<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a>), and is pushing for dividends, new buybacks, and cost cuts. The firm asserts such actions can lead Juniper's shares to rise to the $35-$40 range. (<a href=\"http://www.sec.gov/Archives/edgar/data/904495/000101359414000026/juniper13d-011014.htm\" target=\"_blank\">13D</a>)</li>\n<li>The disclosure comes shortly after Elliott <a href=\"https://seekingalpha.com/news/1497761-elliott-management-offers-to-buy-riverbed-for-19-share\" target=\"_blank\">made an offer</a> to buy another networking hardware name, Riverbed (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a>). Riverbed and Juniper have largely complementary product lines; might Elliott push for a merger between the companies? <a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"green\">+0.9%</font> premarket.</li>\n<li>Less than two weeks ago, Cantor cited the potential for \"shareholder-enhancing activities\" as a reason for declaring Juniper <a href=\"https://seekingalpha.com/news/1488861-cantors-white-calls-apple-splunk-tableau-juniper-his-top-2014-picks\" target=\"_blank\">a top 2014 pick</a>. The company has $3B in net cash/investments, and currently doesn't pay a dividend.</li>\n<li>Juniper rallied on Friday after an unknown trader made a <a href=\"https://seekingalpha.com/news/1503201-juniper-rallies-following-59_3m-options-bet\" target=\"_blank\">$59.3M options bet</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504061\" data-linked=\"Elliott Management obtains Juniper stake, shares +5.5% premarket\" data-tweet=\"$JNPR $JNPR $RVBD - Elliott Management obtains Juniper stake, shares +5.5% premarket https://seekingalpha.com/news/1504061-elliott-management-obtains-juniper-stake-shares-plus-5_5-percent-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/1504061-elliott-management-obtains-juniper-stake-shares-plus-5_5-percent-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1504041\" data-ts=\"1389622039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1504041-protalix-provides-2014-outlook-shares-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix provides 2014 outlook, shares rise</a></h4><ul>\n<li>Shares of Protalix Biotherapeutics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a>) are higher by <font color=\"green\">7.3%</font> in early action.</li>\n<li>The company is out with its FY14 outlook (to be presented at the JPMorgan Healthcare Conference).</li>\n<li>CEO David Aviezer says he \"expects to see sales of Elelyso increase across all approved and launched territories, primarily in the United States, Israel, Brazil, Chile and Mexico.\"</li>\n<li>PLX also intends to provide data from its Gaucher and Fabry disease clinical programs.</li>\n<li>Other 2014 highlights: PLX sees its collaboration with Pfizer continuing to be profitable and says it hopes to work with \"national and regional providers\" on agreements for Elelyso; the company also plans to initiate the next phase of the Oral GCD clinical trial program in H2; also on deck is an IND \"enabling the initiation of a Phase I clinical trial of PRX-110\" in CF. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1504041\" data-linked=\"Protalix provides 2014 outlook, shares rise\" data-tweet=\"$PLX - Protalix provides 2014 outlook, shares rise https://seekingalpha.com/news/1504041-protalix-provides-2014-outlook-shares-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1504041-protalix-provides-2014-outlook-shares-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503971\" data-ts=\"1389620922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHC\" target=\"_blank\">CHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503971-china-hydroelectric-agrees-to-going-private-deal-shares-plus-20-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Hydroelectric agrees to going-private deal, shares +20%</a></h4><ul>     <li>China Hydroelectric (NYSE:<a href=\"https://seekingalpha.com/symbol/CHC\" title=\"China Hydroelectric Corporation\">CHC</a>) <font color=\"green\">+20.8%</font> premarket after agreeing to be taken private by parent company CPT Wyndham for $1.17 per ordinary share or $3.51 per ADS.</li>     <li>The deal represents an increase of 18.2% from the original $2.97/ADS offer price submitted by NewQuest in its earlier proposal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1503971\" data-linked=\"China Hydroelectric agrees to going-private deal, shares +20%\" data-tweet=\"$CHC - China Hydroelectric agrees to going-private deal, shares +20% https://seekingalpha.com/news/1503971-china-hydroelectric-agrees-to-going-private-deal-shares-plus-20-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1503971-china-hydroelectric-agrees-to-going-private-deal-shares-plus-20-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503961\" data-ts=\"1389620880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABUS\" target=\"_blank\">ABUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503961-tekmira-inks-option-agreement-with-monsanto-shares-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tekmira inks option agreement with Monsanto, shares rise</a></h4><ul>\n<li>Shares of Tekmira Pharmaceuticals (TKMR) are up <font color=\"green\">30%</font> before the bell.</li>\n<li>The company says it has signed an option agreement under which Monsanto (NYSE:<a href=\"https://seekingalpha.com/symbol/MON\" title=\"Monsanto Company\">MON</a>) can license TKMR's delivery technology.</li>\n<li>TKMR says the value of the option could reach $86.2M \"following the successful completion of milestones.\"</li>\n<li>TKMR also notes it is expecting a \"near-term payment\" of $16.5M.</li>\n<li>MON has conducted initial testing of the technology in agriculture and the new agreement \"will now focus on the development of new innovative biological solutions for farmers.\"</li>\n<li>The option period is expected to be four years. (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503961\" data-linked=\"Tekmira inks option agreement with Monsanto, shares rise\" data-tweet=\"$ABUS $ABUS $MON - Tekmira inks option agreement with Monsanto, shares rise https://seekingalpha.com/news/1503961-tekmira-inks-option-agreement-with-monsanto-shares-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/1503961-tekmira-inks-option-agreement-with-monsanto-shares-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503941\" data-ts=\"1389620430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSM\" target=\"_blank\">NSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503941-nationstar-raised-to-a-buy-at-sterne-agee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nationstar raised to a Buy at Sterne Agee</a></h4><ul>\n<li>Sterne Agee attempts to step into the big decline in Nationstar Mortgage (NYSE:<a href=\"https://seekingalpha.com/symbol/NSM\" title=\"Nationstar Mortgage Holdings\">NSM</a>), boosting<a href=\"http://www.streetinsider.com/Analyst+PT+Change/Sterne+Agee+Upgrades+Nationstar+Mortgage+%28NSM%29+to+Buy/9047700.html\" target=\"_blank\"> to a Buy</a>, though adjusting the price target to reflect the stock's new reality - a cut to $40 from $45.</li>\n<li>The stock <a href=\"https://seekingalpha.com/news/1396612-nasty-session-for-mortgage-servicers\" target=\"_blank\">has fallen</a> and can't get up amid a slowdown in the mortgage origination business and maybe lighter-than-hoped-for sales of MSRs by the nation's banks.</li>\n<li>Shares <font color=\"green\">+1.2%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503941\" data-linked=\"Nationstar raised to a Buy at Sterne Agee\" data-tweet=\"$NSM - Nationstar raised to a Buy at Sterne Agee https://seekingalpha.com/news/1503941-nationstar-raised-to-a-buy-at-sterne-agee?source=tweet\" data-url=\"https://seekingalpha.com/news/1503941-nationstar-raised-to-a-buy-at-sterne-agee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503921\" data-ts=\"1389620189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BONT\" target=\"_blank\">BONT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503921-bon-ton-stores-dives-after-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bon-Ton Stores dives after profit warning</a></h4><ul> <li>Shares of Bon-Ton Stores (<a href=\"https://seekingalpha.com/symbol/BONT\" title=\"The Bon-Ton Stores, Inc.\">OTC:BONT</a>) crumble after the retailer <a href=\"https://seekingalpha.com/news/1503021-bon-ton-stores-halted-after-warning-on-profits\" target=\"_blank\">issued</a> a harsh warning on profits following a brutal December for store traffic.</li>\n<li>After factoring in its sluggish Q4 , the company says full-year same-store sales slid 3.5.</li> <li>BONT <font color=\"red\">-17.8%</font> to $12.75 premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1503921\" data-linked=\"Bon-Ton Stores dives after profit warning\" data-tweet=\"$BONT - Bon-Ton Stores dives after profit warning https://seekingalpha.com/news/1503921-bon-ton-stores-dives-after-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/1503921-bon-ton-stores-dives-after-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503861\" data-ts=\"1389619418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503861-cell-therapeutics-regains-rights-to-cancer-compounds-from-novartis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cell Therapeutics regains rights to cancer compounds from Novartis</a></h4><ul>\n<li>Cell Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a>) will reacquire the rights to <a href=\"https://seekingalpha.com/news/search?query=pixuvri\" target=\"_blank\">Pixuvri</a> and Opaxio from Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) on the condition that NVS receive \"certain potential payments ... based on sales [and] any sublicens[ing].\"</li>\n<li>\"Regaining full rights to these two anti-cancer agents ... provides us with the flexibility to manage these assets within the context of our overall product portfolio strategy,\" CTIC CEO James Bianco says. (PR)</li>\n<li>Recently: <a href=\"https://seekingalpha.com/news/1492531-cell-therapeutics-rallies-on-nice-nod-for-pixuvri\" target=\"_blank\">CTiC rallies on NICE nod for Pixuvri</a>\n</li>\n<li>CTIC <font color=\"green\">+12%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503861\" data-linked=\"Cell Therapeutics regains rights to cancer compounds from Novartis\" data-tweet=\"$CTIC $CTIC $NVS - Cell Therapeutics regains rights to cancer compounds from Novartis https://seekingalpha.com/news/1503861-cell-therapeutics-regains-rights-to-cancer-compounds-from-novartis?source=tweet\" data-url=\"https://seekingalpha.com/news/1503861-cell-therapeutics-regains-rights-to-cancer-compounds-from-novartis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503841\" data-ts=\"1389619023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROSG-OLD\" target=\"_blank\">ROSG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503841-rosetta-genomics-rallies-on-deal-with-mystery-major\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rosetta Genomics rallies on deal with mystery major</a></h4><ul>\n<li>Rosetta Genomics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ROSG-OLD\" title=\"Rosetta Genomics Ltd.\">ROSG-OLD</a>) soars <font color=\"green\">25%</font> premarket.</li>\n<li>The company says it has \"signed a master service provider agreement with an undisclosed major global biopharmaceutical company.\"</li>\n<li>The deal calls for ROSG to \"provide its microRNA profiling and other services pursuant to a collaboration in important areas of unmet medical need.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503841\" data-linked=\"Rosetta Genomics rallies on deal with mystery major\" data-tweet=\"$ROSG-OLD - Rosetta Genomics rallies on deal with mystery major https://seekingalpha.com/news/1503841-rosetta-genomics-rallies-on-deal-with-mystery-major?source=tweet\" data-url=\"https://seekingalpha.com/news/1503841-rosetta-genomics-rallies-on-deal-with-mystery-major\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503781\" data-ts=\"1389618287\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEN\" target=\"_blank\">WEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503781-wendys-to-new-heights-after-strong-guidance-and-new-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wendy&#39;s to new heights after strong guidance and new buyback</a></h4><ul> <li>Wendy's (NYSE:<a href=\"https://seekingalpha.com/symbol/WEN\" title=\"The Wendy's Company\">WEN</a>) has a few more treats for investors today in addition to its <a href=\"https://seekingalpha.com/news/1503651-wendys-sees-solid-q4-traffic-updates-guidance\" target=\"_blank\">2014 profit guidance</a> which topped the consensus analyst estimate.</li> <li>The company authorized a $275M share repurchase program and will launch a Dutch auction to pick up the shares.</li> <li>WEN <font color=\"green\">+8.7%</font> premarket</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1503781\" data-linked=\"Wendy&#39;s to new heights after strong guidance and new buyback\" data-tweet=\"$WEN - Wendy&#39;s to new heights after strong guidance and new buyback https://seekingalpha.com/news/1503781-wendys-to-new-heights-after-strong-guidance-and-new-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/1503781-wendys-to-new-heights-after-strong-guidance-and-new-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503761\" data-ts=\"1389618096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503761-alnylam-pharma-acquires-merck-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam Pharma acquires Merck unit</a></h4><ul>\n<li>Alnylam Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a>) acquires Merck (NYSE:<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a>) subsidiary Sirna Therapeutics for $175M upfront in cash and equity \u2014 MRK may also get milestone payments and \"single-digit\" royalties tied to development and sales.</li>\n<li>The deal gives ALNY \"pre-clinical [RNAi] therapeutic       candidates, chemistry, siRNA-conjugate and other delivery technologies,\" which CEO John Maraganore says complement the company's existing portfolio. (PR)</li>\n<li>See also: <a href=\"https://seekingalpha.com/news/1503481-sanofi-deepens-relationship-with-alnylam-in-700m-deal\" target=\"_blank\">SNY deepens relationship with ALNY in $700M deal</a>\n</li>\n<li>Also: <a href=\"https://seekingalpha.com/news/1503031-alnylam-pharma-gives-pipeline-update\" target=\"_blank\">ALNY gives pipeline update</a>\n</li>\n<li>ALNY <font color=\"green\">+30%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503761\" data-linked=\"Alnylam Pharma acquires Merck unit\" data-tweet=\"$ALNY $ALNY $MRK - Alnylam Pharma acquires Merck unit https://seekingalpha.com/news/1503761-alnylam-pharma-acquires-merck-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/1503761-alnylam-pharma-acquires-merck-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503701\" data-ts=\"1389617295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SODA\" target=\"_blank\">SODA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503701-sodastream-disappoints-in-q4-shares-minus-11_8-percent-early\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SodaStream disappoints in Q4, shares -11.8% early</a></h4><ul> <li>SodaStream (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SODA\" title=\"SodaStream International\">SODA</a>) says it missed profit targets after a disappointing Q4.</li>\n<li>Higher product costs amid a \"challenging\" holiday season took a toll on margins.</li> <li>The company expects a final tally for 2103 of $562M in sales and net income of $41.5M.</li> <li>SODA <font color=\"red\">-11.8%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1503701\" data-linked=\"SodaStream disappoints in Q4, shares -11.8% early\" data-tweet=\"$SODA - SodaStream disappoints in Q4, shares -11.8% early https://seekingalpha.com/news/1503701-sodastream-disappoints-in-q4-shares-minus-11_8-percent-early?source=tweet\" data-url=\"https://seekingalpha.com/news/1503701-sodastream-disappoints-in-q4-shares-minus-11_8-percent-early\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503671\" data-ts=\"1389616623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503671-jinkosolar-to-separate-downstream-pv-project-unit-shares-plus-2_5-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar to separate downstream PV project unit, shares +2.5%</a></h4><ul>\n<li>JinkoSolar (NYSE:<a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a>) says it plans to separate its downstream solar PV project business, and may consider a spinoff or sale of the unit.</li>\n<li>The board will consider a broad range of alternatives including an IPO, pre-IPO financing, or a merger and acquisition of the business.</li>\n<li>JKS <font color=\"green\">+2.5%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503671\" data-linked=\"JinkoSolar to separate downstream PV project unit, shares +2.5%\" data-tweet=\"$JKS - JinkoSolar to separate downstream PV project unit, shares +2.5% https://seekingalpha.com/news/1503671-jinkosolar-to-separate-downstream-pv-project-unit-shares-plus-2_5-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1503671-jinkosolar-to-separate-downstream-pv-project-unit-shares-plus-2_5-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503651\" data-ts=\"1389615949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEN\" target=\"_blank\">WEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503651-wendys-sees-solid-q4-traffic-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wendy&#39;s sees solid Q4 traffic, updates guidance</a></h4><ul> <li>Wendy's (NYSE:<a href=\"https://seekingalpha.com/symbol/WEN\" title=\"The Wendy's Company\">WEN</a>) reports same-restaurant sales rose 3.1% in Q4.</li> <li>Promotions on the Pretzel Pub Chicken sandwich and Bacon Portabella Melt on Brioche helped to drive traffic during the period.</li> <li>The company expects 2014 EPS of $0.34-$0.36 on same-restaurant sales growth of 2.5% to 3.5%.</li> <li>Q4 EPS is guided to $0.10-$0.11 vs. $0.06 consensus.</li>\n<li>WEN <font color=\"green\">+5.7%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1503651\" data-linked=\"Wendy&#39;s sees solid Q4 traffic, updates guidance\" data-tweet=\"$WEN - Wendy&#39;s sees solid Q4 traffic, updates guidance https://seekingalpha.com/news/1503651-wendys-sees-solid-q4-traffic-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/1503651-wendys-sees-solid-q4-traffic-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503641\" data-ts=\"1389615645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503641-twitter-gets-lift-from-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter gets lift from Goldman</a></h4><ul>\n<li>Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) is <font color=\"green\">ahead 3%</font> premarket as Goldman's Heath Terry <a href=\"http://www.streetinsider.com/Analyst+Comments/Twitter+%28TWTR%29+Priced+Target+Lifted+at+Goldman+Sachs+on+Accelerated+Product+Innovation/9047537.html\" target=\"_blank\">boosts his price target </a>on the Buy-rated stock to $65 from $46.</li>\n<li>\"Over the course of the past quarter we have seen significant acceleration in the pace of Twitter's product innovation,\" says Terry, \"with nearly 4x the number of enhancements designed to drive user growth, engagement, and incremental monetization as in any prior quarter ... we believe this accelerating pace is more indicative of the company\u2019s ongoing capabilities now that site stability issues have been resolved.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1503641\" data-linked=\"Twitter gets lift from Goldman\" data-tweet=\"$TWTR - Twitter gets lift from Goldman https://seekingalpha.com/news/1503641-twitter-gets-lift-from-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1503641-twitter-gets-lift-from-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503591\" data-ts=\"1389614595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPR\" target=\"_blank\">EXPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503591-express-lowers-guidance-after-weak-store-traffic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Express lowers guidance after weak store traffic</a></h4><ul>     <li>Express (NYSE:<a href=\"https://seekingalpha.com/symbol/EXPR\" title=\"Express, Inc.\">EXPR</a>) says it experienced an unexpected drop in traffic following Thanksgiving which forced it to take a promotional stance through January.</li>     <li>The company says it now expects Q4 comparable-store sales growth of 0% to low single digits.</li>     <li>Guidance for Q4 is lowered to $1.37-$1.51, from a prior outlook of $1.46-$1.51.</li>     <li>EXPR <font color=\"red\">-3.3%</font> premarket</li> </ul><div class=\"tiny-share-widget\" data-id=\"1503591\" data-linked=\"Express lowers guidance after weak store traffic\" data-tweet=\"$EXPR - Express lowers guidance after weak store traffic https://seekingalpha.com/news/1503591-express-lowers-guidance-after-weak-store-traffic?source=tweet\" data-url=\"https://seekingalpha.com/news/1503591-express-lowers-guidance-after-weak-store-traffic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503541\" data-ts=\"1389613785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503541-lululemon-warns-on-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon warns on Q4 results</a></h4><ul> <li>Lulemon (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LULU\" title=\"Lululemon Athletica Inc.\">LULU</a>) provides an update on its outlook for Q4 ahead of a presentation by execs with the company at the ICR XChange Conference.</li> <li>CFO John Currie says December results were on track, but in January traffic and sales trends both decelerated meaningfully.</li> <li>The retailer cuts its outlook for Q4 EPS to $0.71-$0.73, from previous guidance of $0.78-$0.80.</li> <li>LULU <font color=\"red\">-8.9%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1503541\" data-linked=\"Lululemon warns on Q4 results\" data-tweet=\"$LULU - Lululemon warns on Q4 results https://seekingalpha.com/news/1503541-lululemon-warns-on-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1503541-lululemon-warns-on-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1503531\" data-ts=\"1389609181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1503531-global-equities-mixed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global equities mixed</a></h4><ul>   <li>Asian shares trade mixed and European equities are higher, but U.S. stock futures are lower.</li>    <li>The disappointing U.S. jobs report on Friday is one factor affecting sentiment, as it may mean that the Fed will taper more slowly. A fall in Treasury yields at the end of last week is <a href=\"http://www.reuters.com/article/2014/01/13/us-markets-global-idUSBRE96S00E20140113\" target=\"_blank\">weighing on the dollar</a> against some currencies, with the greenback <font color='red'>-0.7%</font> vs the yen. Japanese markets are closed but Nikkei futures are <font color='red'>-1.3%</font> .</li>    <li>Banks are enjoying a good day after regulators said they would <a href=\"https://seekingalpha.com/news/1503521-regulators-ease-basel-leverage-ratio-requirements\" target=\"_blank\">ease Basel requirements</a> related to leverage ratios.</li>    <li>Hong Kong <font color='green'>+0.2%</font>, China <font color='red'>-0.2%</font>, India <font color='green'>+1.8%</font>.</li>    <li>EU Stoxx 50 <font color='green'>+0.3%</font>, London <font color='green'>+0.1%</font>, Paris <font color='green'>+0.2%</font>, Frankfurt <font color='green'>+0.3%</font>, Milan <font color='green'>+0.6%</font>, Madrid <font color='green'>+0.6%</font>.</li>     <li>U.S. stock futures: Dow <font color='red'>-0.2%</font>. S&amp;P <font color='red'>-0.2%</font>. Nasdaq <font color='red'>-0.25%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"1503531\" data-linked=\"Global equities mixed\" data-tweet=\"Global equities mixed https://seekingalpha.com/news/1503531-global-equities-mixed?source=tweet\" data-url=\"https://seekingalpha.com/news/1503531-global-equities-mixed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 AM </div></div></li>","count":66,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}